SLC16A2 and Allan-Herndon-Dudley syndrome: This has been clearly demonstrated by studies showing that MCT8 mutations affect transporter characteristics and consequently TH transport efficiency, giving rise to the phenotypic variability observed in AHDS patients25,30,31.